Share Name Share Symbol Market Type Share ISIN Share Description
GlaxoSmithKline LSE:GSK London Ordinary Share GB0009252882 ORD 25P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -19.00p -1.45% 1,294.50p 1,294.50p 1,295.00p 1,311.50p 1,294.00p 1,310.00p 4,101,780 13:56:10
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology 27,889.0 1,939.0 18.8 68.9 63,671.68

GlaxoSmithKline Share Discussion Threads

Showing 15776 to 15800 of 15800 messages
Chat Pages: 632  631  630  629  628  627  626  625  624  623  622  621  Older
DateSubjectAuthorDiscuss
21/11/2017
14:00
gents - you could well be right. only the future knows for sure and we just have to take our positions until then.
unastubbs
21/11/2017
13:54
There is no crash, there are rotations out of certain assets and into others. The markets are likely to hit a bump as institutions take year long profits out of tech and finance. Hopefully pharma and other defensives will then see a long awaited recovery. What is happening here is not limited to just GSK.
romeike
21/11/2017
13:31
good to see monty has turned bear again. pretty comical how you do that, but still...what has changed, monty, in the last three weeks or so? i'm not going to go through your posts but it was abt that when you were predicting they would go higher...
unastubbs
21/11/2017
13:29
GLAXO tends to go in cycles, the charts tell their own story, £12 - £13 is a buy, £16 to £18 is a sell, it's as simple as that.
eastbourne1982
21/11/2017
13:29
A major correction may not effect these as much as you think as it could also see a move away from higher risk shares into more defensive ones.
tim 3
21/11/2017
13:28
Low can obviously go much lower however for the index to tank individual equity values will have to plummet, plenty are already low. Tell me which FTSE 100 shares you believe will drop the most ?
eastbourne1982
21/11/2017
13:25
all shares, equities as an asset class. i've been in this game a while a now, one thing i know is that "low" can go much lower...
unastubbs
21/11/2017
13:15
This is a long term buy at anything under £13, it may well go lower short term however you generally miss the boat waiting for the absolute bottom.
eastbourne1982
21/11/2017
13:13
unastubbs, tell me which shares will make the FTSE correct, plenty are already pretty low despite the FTSE 100 / 250 being relatively high.
eastbourne1982
21/11/2017
13:13
Is GSK following in the footsteps of BT as regards the SP???
abdullla
21/11/2017
13:09
not sure why you're calling me "junior" and "sonny". i'm 45! glad you have superior indicators. good luck with your trade. i mean it. i have no position here, but my sense is this one will fall with the ftse when it finally corrects...
unastubbs
21/11/2017
13:05
Best to keep it calm, none of us have the gift of prescience. As the share price was over 15 just 4 weeks ago, 1225-1250 approx, is not a huge call.
essentialinvestor
21/11/2017
13:03
I don't use an "SP graph", junior, my indicators are vastly superior and they're all turning up.
woodhawk
21/11/2017
13:00
Go and peddle your rose tinted stories elsewehere (sic), sonny. and check the share price graph while you're doing it!
unastubbs
21/11/2017
12:54
Big bounce coming, Monty, 1400p here we come!! 23p divi next time too!!
woodhawk
21/11/2017
12:51
1250p looks on the cards now.
montyhedge
21/11/2017
12:38
MJ19Funny enough was looking at that last night on the charts.Might take a wider market sell off to get there though.
tim 3
21/11/2017
12:34
Go and peddle your apocalypse stories elsewehere, sonny.
woodhawk
21/11/2017
12:06
beware a wider market sell-off is coming...you think it's bad now for gsk? wait and find out...
unastubbs
21/11/2017
11:49
Stop scare-mongering. Alternatively, could go to 1700p, anything is possible.
woodhawk
21/11/2017
11:22
There is major support at 1225. I hope it doesn't go there but at the moment anything is possible.
mj19
21/11/2017
11:13
Don't mention the dividend!! ) There look to be three other factors driving this -firstly a worry that GILD new HIV medication will take share from 2018. A concern that respiratory is under significant margin pressure. The lack of depth in the longer term pipeline. GSK have launched multiple new products recently, however where is the next major prospect coming from? The oncology pipeline perhaps, may be.
essentialinvestor
21/11/2017
10:51
Never even heard of the latest company making headlines today, I'm aware of one of the medications mentioned. The story widely reported now.
essentialinvestor
21/11/2017
10:47
It may not be long before a bid comes in with a view to breaking it up and selling off maybe 2 of the 3 businesses which GSK is running virtually separately.
tradermichael
21/11/2017
10:43
Thank goodness for that :-)
philanderer
Chat Pages: 632  631  630  629  628  627  626  625  624  623  622  621  Older
Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P:40 V: D:20171121 14:11:19